$5,94
▼ $-0,17
(-2,78%)
Vol 2.4M
6
Skor Kualitas
fail
Pendapatan ✗
Laba Bersih ✗
>IPO ✗
Kap. Pasar
$1.4B
ROE
-36,9%
Margin
-14,2%
D/E
131,02
Beta
0,51
52W
$3–$7
Konsensus Wall Street
18 analis · Apr 202610
Beli Kuat
7
Beli
1
Tahan
0
Jual
0
Jual Kuat
94,4%
Peringkat Beli
Grafik Harga
Saham Serupa
Pendapatan
Tingkat beat: 50,0%| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Des 2025 | $0,01 | $0,00 | $-0,01 |
| Sep 2025 | $-0,06 | $0,00 | +$0,06 |
| Jun 2025 | $-0,14 | $-0,08 | +$0,06 |
| Mar 2025 | $-0,12 | $-0,17 | $-0,05 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Pendapatan | $116.1M | $74.1M | $97.7M | $110.3M | $125.2M |
| Laba Bersih | $4.6M | -$41.1M | -$19.1M | -$969K | -$407K |
Tren Fundamental
| Metrik | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -36.6% | -36.6% | -36.6% | -36.9% | -36.9% | -36.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -19.5% | -14.6% | -14.6% | -14.2% | -14.2% | -14.2% |
| Gross Margin | 87.3% | 84.8% | 84.8% | 88.2% | 88.2% | 88.2% |
| D/E Ratio | 144.37 | 144.37 | 144.37 | 131.02 | 131.02 | 131.02 |
| Current Ratio | 4.30 | 4.30 | 4.30 | 4.41 | 4.41 | 4.41 |
Rasio Utama
ROA (TTM)
-12,6%
P/S (TTM)
3,56
P/B
6,9
EPS (TTM)
$-0,24
CF/Share
$0,01
Pertumbuhan Pendapatan 3T
+220,9%
52W High
$6,78
52W Low
$3,21
$3,21
Rentang 52 Minggu
$6,78
Kesehatan Keuangan
Arus Kas Bebas
$20.6M
Utang Bersih
$140.0M
Kas
$68.0M
Total Utang
$208.0M
Per tanggal Des 31, 2025
Як ARDX виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка ARDX vs аналоги Biotechnology
P/E
—
▼
0%
di bawah
rekan
(18,8)
vs Rekan
vs Industri
Undervalued
P/S
3,6
▼
72%
di bawah
rekan
(12,9)
vs Rekan
vs Industri
Undervalued
P/B
6,9
▲
182%
di atas
rekan
(2,5)
vs Rekan
vs Industri
Overvalued
Дивідендна дохідність
—
▼
0%
di bawah
rekan
(0,0%)
vs Rekan
vs Industri
Yield rendah
Прибутковість ARDX vs аналоги Biotechnology
ROE
-36,9%
▲
45%
di atas
rekan
(-67,3%)
vs Rekan
vs Industri
Di bawah rata-rata
Net margin
-14,2%
▲
95%
di atas
rekan
(-286,8%)
vs Rekan
vs Industri
Di bawah rata-rata
Валова маржа
88,2%
▲
12%
di atas
rekan
(78,6%)
vs Rekan
vs Industri
Lemah
ROA
-12,6%
▲
73%
di atas
rekan
(-46,7%)
vs Rekan
vs Industri
Tingkat atas
Фінансове здоровʼя ARDX vs аналоги Biotechnology
D/E ratio
131,0
▼
0%
di bawah
rekan
(0,0)
vs Rekan
vs Industri
Utang tinggi
Поточна ліквідність
4,4
▼
1%
di bawah
rekan
(4,4)
vs Rekan
vs Industri
Sejajar
Beta
0,5
▼
48%
di bawah
rekan
(1,0)
vs Rekan
vs Industri
Lebih volatil
Радар фундаменталів ARDX
ARDX
Median rekan
Industri
ARDX прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
ARDX vs аналоги: ключові метрики
Aktivitas Orang Dalam
NeutralPembelian
0
Penjualan
0
RAAB MICHAEL G
Chief Executive Officer · Mar 16
20833 shs
RAAB MICHAEL G
Chief Executive Officer · Mar 16
41666 shs
RAAB MICHAEL G
Chief Executive Officer · Feb 24
20833 shs
RAAB MICHAEL G
Chief Executive Officer · Feb 24
41666 shs
MOTT DAVID M
Director · Feb 20
333333 shs
RAAB MICHAEL G
Chief Executive Officer · Feb 20
45982 shs
WILLIAMS LAURA A
Officer · Feb 20
8176 shs
KELLIHER MICHAEL
Officer · Feb 20
9595 shs
FOSTER ERIC DUANE
Officer · Feb 20
10439 shs
BRADY JAMES PARKER
Officer · Feb 20
2543 shs
Terakhir 90 hari
Pemegang Terbesar
Top 5: 32,0%Blackrock Inc.
8,62%
$115.8M
Vanguard Group Inc
7,74%
$104.0M
Janus Henderson Group PLC
5,92%
$79.5M
State Street Corporation
4,86%
$65.3M
Millennium Management Llc
4,86%
$65.3M
Per tanggal Des 31, 2025